Showing results (7651-7660 of 10,083) with videos related to
Sort By:
Pageof 1,009
Current Pharmaceutical Design|January 11, 2012
Progress in gene and cell therapy for cystic fibrosis lung diseaseUta Griesenbach, Eric W F W AltonCurrent Pharmaceutical Design|January 11, 2012
The multiple layers of signaling selectivity at protease-activated receptorsIason Kyriazis, John Ellul, Paraskevi Katsakiori, et al.Current Pharmaceutical Design|January 11, 2012
GRK2 at the control shaft of cellular metabolismMichele Ciccarelli, Ersilia Cipolletta, Guido IaccarinoCurrent Pharmaceutical Design|January 11, 2012
Current treatment strategies for multiple sclerosis - efficacy versus neurological adverse effectsMartin S Weber, Til Menge, Klaus Lehmann-Horn, et al.Current Pharmaceutical Design|March 27, 2012
Cucurbitacins as inducers of cell death and a rich source of potential anticancer compoundsJ L Ríos, I Andújar, J M Escandell, et al.Current Pharmaceutical Design|February 23, 2012
Nuclear PI-PLCβ1 and myelodysplastic syndromes: genetics and epigeneticsMatilde Y Follo, Sara Mongiorgi, Carlo Finelli, et al.Current Pharmaceutical Design|February 23, 2012
Microbubbles as a vehicle for gene and drug delivery: current clinical implications and future perspectivesNicolas A Geis, Hugo A Katus, Raffi BekeredjianCurrent Pharmaceutical Design|February 23, 2012
Role of contrast-enhanced ultrasound in the follow-up of endo-vascular aortic aneurysm repair: an effective and safe surveillance methodMariarosaria Fabrizia Giannoni, Michele Citone, Michele Rossini, et al.Current Pharmaceutical Design|January 26, 2012
Development of radiolabeled compounds for myocardial perfusion imagingXiao Lin, Junbo Zhang, Xuebin Wang, et al.Current Pharmaceutical Design|February 4, 2012
Non-systemic drugs: a critical reviewDominique CharmotPageof 1,009